rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Robert R. Banks Jr.

President and CEO

Company insider

Files Form 4 as: President and CEO, Nephros.

In numbers

Trades disclosed
9
Buys
4
Sells
0
Bought
$155K
Sold
$0
Companies
1
Companies where not an officer
0
First trade
14 Aug 2023
Last trade
23 Mar 2026
Last filed
25 Mar 2026

Companies traded

Where they are an officer
NEPH NephrosDirector, Officer · Medical Devices · last 23 Mar 20264 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
23 Mar 2026filed 25 Mar 2026NEPH NephrosMedical DevicesSEC FORM 4 Code M$173K120,000 at $1.44filing
23 Mar 2026filed 25 Mar 2026NEPH Nephrosoption or derivative · Medical DevicesSEC FORM 4 Code M—120,000 at $0.00filing
23 Mar 2026filed 25 Mar 2026NEPH Nephrosoption or derivative · Medical DevicesSEC FORM 4 Code M—120,000 at $0.00filing
23 Mar 2026filed 25 Mar 2026NEPH NephrosMedical DevicesSEC FORM 4 Code M$173K120,000 at $1.44filing
16 May 2024filed 16 May 2024NEPH NephrosMedical DevicesSEC FORM 4 Bought$112K50,000 at $2.24filing
14 May 2024filed 16 May 2024NEPH Nephrosoption or derivative · Medical DevicesSEC FORM 4 Code A—10,406 at $0.00filing
7 Dec 2023filed 11 Dec 2023NEPH NephrosMedical DevicesSEC FORM 4 Bought$40K18,000 at $2.20filing
15 Aug 2023filed 15 Aug 2023NEPH NephrosMedical DevicesSEC FORM 4 Bought$3,2131,901 at $1.69filing
14 Aug 2023filed 15 Aug 2023NEPH NephrosMedical DevicesSEC FORM 4 Bought$14999 at $1.50filing

News

Reviewing Nephros (NASDAQ:NEPH) and MariMed (OTCMKTS:MRMD)NEPH · dailypolitical.com · 10 Oct 2026

0 headlines in the last 90 days name Robert R. Banks Jr.; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care4

Buys in green, sells in red, by the company’s sector.

Related people

WEXFORD CAPITAL LP10% owner · 10% owner at Nephros, filing Form 4 there in the last year
Arthur H. AmronDirector · Director at Nephros, filing Form 4 there in the last year
Judy KrandelChief Financial Officer · Chief Financial Officer at Nephros, filing Form 4 there in the last year